Medtronic Cardiovascular
Clinical trials sponsored by Medtronic Cardiovascular, explained in plain language.
-
New heart valve procedure offers hope for patients too sick for surgery
Disease control CompletedThis study tested a new way to replace a narrowed heart valve without open-heart surgery. It involved 782 people with severe aortic stenosis who were considered too high-risk for traditional surgery. The procedure, called TAVI, uses a thin tube to place a new valve inside the hea…
Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New anchor device aims to secure aortic aneurysm repairs
Disease control CompletedThis registry tracked over 1,000 patients who received the Heli-FX EndoAnchor device during endovascular repair of aortic aneurysms. The device is designed to help hold the endograft in place and prevent leaks. Patients were followed for up to 5 years to see how safe and effectiv…
Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New heart valve study aims to cut complications in aortic stenosis patients
Disease control CompletedThis study tested an optimized care plan for people with a narrowed aortic heart valve who received a new valve through a catheter (TAVR). Over 1,100 patients were enrolled to see if the improved care pathway could lower risks like death, stroke, and the need for a pacemaker. The…
Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New heart valve shows promise for High-Risk patients
Disease control CompletedThis study tested a new heart valve called Evolut PRO in 638 people with severe aortic stenosis who were at high risk for open-heart surgery. The valve was implanted using a thin tube through an artery, avoiding major surgery. Results showed that only 3.3% of patients died within…
Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Jun 26, 2026 14:57 UTC